Wells Fargo & Company Ideaya Biosciences, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 153,612 shares of IDYA stock, worth $3.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
153,612
Previous 149,224 2.94%
Holding current value
$3.86 Million
Previous $5.24 Million 7.12%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$30.37 - $43.05 $133,263 - $188,903
4,388 Added 2.94%
153,612 $4.87 Million
Q2 2024

Aug 13, 2024
BUY
$34.37 - $43.46 $823,917 - $1.04 Million
23,972 Added 19.14%
149,224 $5.24 Million
Q1 2024

May 10, 2024
BUY
$34.2 - $47.13 $3.69 Million - $5.09 Million
108,031 Added 627.32%
125,252 $5.5 Million
Q4 2023

Feb 09, 2024
SELL
$24.59 - $35.83 $459,095 - $668,946
-18,670 Reduced 52.02%
17,221 $612,000
Q3 2023

Nov 13, 2023
SELL
$21.07 - $29.77 $153,221 - $216,487
-7,272 Reduced 16.85%
35,891 $968,000
Q2 2023

Aug 15, 2023
BUY
$13.33 - $25.53 $180,688 - $346,059
13,555 Added 45.78%
43,163 $1.01 Million
Q1 2023

May 12, 2023
BUY
$13.49 - $18.72 $392,437 - $544,583
29,091 Added 5626.89%
29,608 $406,000
Q4 2022

Feb 13, 2023
SELL
$14.47 - $18.17 $15,627 - $19,623
-1,080 Reduced 67.63%
517 $9,000
Q3 2022

Nov 14, 2022
BUY
$9.24 - $15.79 $1,820 - $3,110
197 Added 14.07%
1,597 $24,000
Q2 2022

Aug 12, 2022
SELL
$8.28 - $13.88 $258,932 - $434,055
-31,272 Reduced 95.71%
1,400 $19,000
Q1 2022

May 16, 2022
SELL
$11.18 - $24.02 $101,000 - $216,996
-9,034 Reduced 21.66%
32,672 $365,000
Q4 2021

Feb 14, 2022
BUY
$20.95 - $26.88 $385,982 - $495,237
18,424 Added 79.13%
41,706 $986,000
Q3 2021

Nov 15, 2021
SELL
$17.26 - $27.08 $33,363 - $52,345
-1,933 Reduced 7.67%
23,282 $593,000
Q2 2021

Aug 16, 2021
BUY
$17.76 - $24.83 $91,552 - $127,998
5,155 Added 25.7%
25,215 $529,000
Q1 2021

May 13, 2021
SELL
$13.48 - $23.77 $227,852 - $401,784
-16,903 Reduced 45.73%
20,060 $472,000
Q4 2020

Feb 09, 2021
BUY
$12.17 - $17.52 $290,972 - $418,885
23,909 Added 183.15%
36,963 $517,000
Q3 2020

Nov 05, 2020
BUY
$11.22 - $14.46 $71,112 - $91,647
6,338 Added 94.37%
13,054 $164,000
Q2 2020

Aug 13, 2020
BUY
$3.59 - $18.57 $23,984 - $124,066
6,681 Added 19088.57%
6,716 $95,000
Q1 2020

May 14, 2020
BUY
$3.03 - $10.58 $106 - $370
35 New
35 $0

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.21B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email